Top Clinical Trials Stories


Comment & Analysis »

GlobalData Healthcare

Minoryx’s MIN-102 secures orphan drug designation

On February 22, 2017, Minoryx Therapeutics’ lead pipeline asset, MIN-102, received Orphan Drug Designation from the FDA, following the decision by the European Medicines Agency (EMA) to award...

Minoryx’s MIN-102 secures orphan drug designation
GlobalData Healthcare

Competition is heating up in long-acting growth hormones for children

Competition is heating up in long-acting growth hormones for children
GlobalData Healthcare

Promising preliminary data from Phase II study encourages Axovant to expand trial

Promising preliminary data from Phase II study encourages Axovant to expand trial
GlobalData Healthcare

When faster is not better: the 'surrogate' example

When faster is not better: the 'surrogate' example
GlobalData Healthcare

The importance of real world evidence in the 21st Century Cures Act

The importance of real world evidence in the 21st Century Cures Act

Company Releases »

ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

SYSTAG Systems Technik
ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

Optimising Development Resources for Efficient Product Development

SYSTAG Systems Technik
Optimising Development Resources for Efficient Product Development

Validated Metal Analysis

Pfanstiehl Validated Metal Analysis

Benefits of Trehalose

Pfanstiehl
Benefits of Trehalose

Pharmaceutical Consultant and FDA Regulatory Strategist

Pharmaceutical Development Group Pharmaceutical Consultant and FDA Regulatory Strategist

Clinical Trials Insights »

Companies »